CWM
RXRX icon

CIBC World Markets’s Recursion Pharmaceuticals RXRX Stock Holding History

CIBC World Markets’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$103K Buy
+25,169
New +$125K ﹤0.01% 1173
2025
Q2 		$212K Sell
41,839
-13,954
-25% -$68.5K ﹤0.01% 1262
2025
Q1 		$295K Buy
55,793
+32,507
+140% +$237K ﹤0.01% 1257
2024
Q4 		$157K Buy
+23,286
New +$157K ﹤0.01% 1163

Other funds holding RXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

CIBC World Markets's RXRX Position: Q4 2025 in Review

CIBC World Markets opened a new position in Recursion Pharmaceuticals (RXRX) in Q4 2025: 25,169 shares worth $103K. The stake represents ﹤0.01% of the portfolio and ranks #1173 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in RXRX as recently as Q2 2025.

CIBC World Markets first reported a position in RXRX in Q4 2024 and has held it in 4 quarters since. The position peaked at $295K in Q1 2025. 333 funds tracked by Wall St. Rank hold RXRX as of Q4 2025.

  • CIBC World Markets held 25,169 shares of Recursion Pharmaceuticals worth $103K as of Q4 2025.
  • Recursion Pharmaceuticals was a new CIBC World Markets position in Q4 2025.
  • Recursion Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1173 holding.
  • CIBC World Markets first reported a position in Recursion Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Recursion Pharmaceuticals position peaked at $295K in Q1 2025.
  • 333 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.